首页> 外文期刊>The Journal of Urology >Conflicting and new risk factors for contrast induced nephropathy.
【24h】

Conflicting and new risk factors for contrast induced nephropathy.

机译:造影剂肾病的矛盾和新的危险因素。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Iodinated contrast medium is commonly used in diagnostic or interventional procedures in uroradiology. Procedures requiring the intravascular administration of iodinated contrast medium are becoming a great source of an iatrogenic disease known as contrast induced nephropathy. Identifying patients at high risk is the first step to minimize the overall risk of contrast induced nephropathy. This review describes conflicting and new risk factors for contrast induced nephropathy. MATERIALS AND METHODS: A MEDLINE/PubMed search from 1966 to 2006 was performed. All articles related to the use of contrast medium and the risk factors for contrast induced nephropathy were reviewed. RESULTS: The classic risk factors for contrast induced nephropathy are preexisting renal failure, diabetes mellitus, advanced age, nephrotoxic agent administration, hypovolemia, use of a large amount of contrast medium or an ionic hyperosmolar contrast medium and congestive heart failure. Metabolic syndrome, prediabetes and hyperuricemia have been identified as new risk factors for contrast induced nephropathy. The use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, renal transplantation, diabetes mellitus with normal renal function, low osmolar contrast medium in patients at high risk for contrast induced nephropathy, multiple myeloma, female gender and cirrhosis have been classified as conflicting risk factors for contrast induced nephropathy. CONCLUSIONS: Patients at risk for contrast induced nephropathy should be identified before urological procedures requiring contrast administration. In addition to the classic risk factors for contrast induced nephropathy, determining the metabolic syndrome, hyperuricemia and prediabetes as well as the use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers before performing procedures using contrast medium seems to be a useful guide to assess the risk of contrast induced nephropathy.
机译:目的:碘化造影剂通常用于尿路放射学的诊断或介入程序。需要在血管内施用碘化造影剂的手术正成为被称为造影剂诱发的肾病的医源性疾病的重要来源。识别高危患者是将造影剂引起的肾病的总体风险降至最低的第一步。这篇综述描述了造影剂引起的肾病的矛盾和新的危险因素。材料与方法:从1966年至2006年进行了MEDLINE / PubMed搜索。所有有关使用造影剂和造影剂诱发肾病的危险因素的文章进行了审查。结果:造影剂诱发的肾病的典型危险因素是预先存在的肾衰竭,糖尿病,高龄,服用肾毒性药物,血容量不足,使用大量造影剂或离子性高渗造影剂和充血性心力衰竭。代谢综合征,糖尿病前期和高尿酸血症已被确定为造影剂引起的肾病的新危险因素。血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂的使用,肾移植,肾功能正常的糖尿病,低渗透压造影剂在造影剂诱发肾病,多发性骨髓瘤,女性和肝硬化的高风险患者中被列为冲突对比剂诱发肾病的危险因素。结论:在需要进行造影剂的泌尿外科手术之前,应确定存在造影剂诱发肾病风险的患者。除了造影剂诱发肾病的经典危险因素外,在使用造影剂进行操作之前确定代谢综合征,高尿酸血症和糖尿病前期以及使用血管紧张素转化酶抑制剂和血管紧张素II受体阻滞剂似乎是评估的有用指南。对比剂诱发肾病的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号